Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07758465
Effectiveness of DIR/Floortime™ in Children With Autism Spectrum DisorderGIFT UniversityCompletedNot Applicable
NCT07758465Completed
Not Applicable
Effectiveness of DIR/Floortime™ in Children With Autism Spectrum DisorderGIFT University
NCT07757646
A Group Intervention for Parents of Autistic Young People With Anorexia Nervosa: An Exploration of How Parents Make Sense of and Integrate Concepts From the Group Into Family LifeKing's College LondonActive Not Recruiting
NCT07757646Active Not Recruiting
—
A Group Intervention for Parents of Autistic Young People With Anorexia Nervosa:...King's College London
NCT07758283
Intergenerational Risk and Resilience of Rohingya in DisplacementInternational Centre for Diarrhoeal Disease Research, BangladeshActive Not Recruiting
NCT07758283Active Not Recruiting
—
Intergenerational Risk and Resilience of Rohingya in DisplacementInternational Centre for...
NCT07758738
Primary Care Screening and Intervention for Patients With Dementia and CaregiversNational Institute on Aging (NIA)Not Yet RecruitingNot Applicable
NCT07758738Not Yet Recruiting
Not Applicable
Primary Care Screening and Intervention for Patients With Dementia and Caregiver...National Institute on Agi...
NCT07757295
Effectiveness of an Online Psychological Support Program for Mothers of Children With AutismHerguner Therapy Private ClinicCompletedNot Applicable
NCT07757295Completed
Not Applicable
Effectiveness of an Online Psychological Support Program for Mothers of Children...Herguner Therapy Private...
NCT07757048
A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patients in the United StatesNovartis PharmaceuticalsCompleted
NCT07757048Completed
—
A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patient...Novartis Pharmaceuticals
NCT07758920
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic NeuralgiaShanghai Yidian Pharmaceutical Technology Development Co., Ltd.RecruitingPhase 2
NCT07758920Recruiting
Phase 2
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Tr...Shanghai Yidian Pharmaceu...
NCT07756697
Leveraging Video Vignettes and Social Media to Promote Safe Firearm Storage Among VeteransVA Office of Research and DevelopmentNot Yet RecruitingNot Applicable
NCT07756697Not Yet Recruiting
Not Applicable
Leveraging Video Vignettes and Social Media to Promote Safe Firearm Storage Amon...VA Office of Research and...
NCT07758296
An Online Game to Help Canadian Adults Identify COVID-19 Vaccine Misinformation With One-Month Follow-UpDigital Public SquareCompletedNot Applicable
NCT07758296Completed
Not Applicable
An Online Game to Help Canadian Adults Identify COVID-19 Vaccine Misinformation...Digital Public Square
NCT07758127
Updates and Insights on HER2 in Breast Cancer in Sohag GovernorateSohag Oncology CenterNot Yet Recruiting
NCT07758127Not Yet Recruiting
—
Updates and Insights on HER2 in Breast Cancer in Sohag GovernorateSohag Oncology Center
NCT07758634
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With HypertensionCRISPR Therapeutics AGRecruitingPhase 1
NCT07758634Recruiting
Phase 1
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants W...CRISPR Therapeutics AG
NCT07757789
Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort StudyNew Valley UniversityRecruitingNot Applicable
NCT07757789Recruiting
Not Applicable
Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort...New Valley University
NCT07759024
Cesarean Delivery Outcomes in Maternal Critical CareSociété Française d'Anesthésie et de RéanimationNot Yet Recruiting
NCT07759024Not Yet Recruiting
—
Cesarean Delivery Outcomes in Maternal Critical CareSociété Française d'Anest...
NCT07758023
Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEFAbbottNot Yet RecruitingNot Applicable
NCT07758023Not Yet Recruiting
Not Applicable
Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mi...Abbott
NCT07758140
Comparative Self-collection for Cervical Cancer Screening Pivotal StudyMel Mont MedicalRecruitingNot Applicable
NCT07758140Recruiting
Not Applicable
Comparative Self-collection for Cervical Cancer Screening Pivotal StudyMel Mont Medical
NCT07757945
Acute Effects of Focal Vibration on Posterior Shoulder Tightness and Tissue Stiffness in Overhead AthletesSaglik Bilimleri UniversitesiActive Not RecruitingNot Applicable
NCT07757945Active Not Recruiting
Not Applicable
Acute Effects of Focal Vibration on Posterior Shoulder Tightness and Tissue Stif...Saglik Bilimleri Universi...
NCT07759037
Fluorescent Hand Hygiene Training and Long-Term Effects in First-Year Nursing StudentsPowiślańska Academy of Applied SciencesNot Yet RecruitingNot Applicable
NCT07759037Not Yet Recruiting
Not Applicable
Fluorescent Hand Hygiene Training and Long-Term Effects in First-Year Nursing St...Powiślańska Academy of Ap...
NCT07757139
High- and Moderate-Intensity Inspiratory Muscle Training on Diaphragm Ultrasound Parameters, Cognition, and Mental HealthHacettepe UniversityCompletedNot Applicable
NCT07757139Completed
Not Applicable
High- and Moderate-Intensity Inspiratory Muscle Training on Diaphragm Ultrasound...Hacettepe University
NCT07756762
Feasibility of Pre-Conditioning FRT in SarcopeniaUniversity of HullNot Yet RecruitingNot Applicable
NCT07756762Not Yet Recruiting
Not Applicable
Feasibility of Pre-Conditioning FRT in SarcopeniaUniversity of Hull
NCT07757542
Safety Assessment of H2 Inhalation in Patients With Mild Cognitive ImpairmentCerebrovaskularni poradna s.r.o.RecruitingPhase 2
NCT07757542Recruiting
Phase 2
Safety Assessment of H2 Inhalation in Patients With Mild Cognitive ImpairmentCerebrovaskularni poradna...
Result Breakdown
Not yet recruiting7 (35%)
Completed5 (25%)
Recruiting5 (25%)
Active, not recruiting3 (15%)
not_applicable12 (60%)
Not Specified5 (25%)
Phase 22 (10%)
Phase 11 (5%)